From Chromosome Karyotyping to Genomic Precision: The Evolution of Diagnostic Technologies in Medicine

Chromosomal diagnostics have evolved significantly over the past several decades, from classical karyotyping to high-resolution genomic technologies. This review traces the development and integration of cytogenetic toolskaryotyping, fluorescence in situ hybridization (FISH), chromosomal microarray analysis (CMA), and whole genome sequencing (WGS)in modern clinical diagnostics. We examine each technologys diagnostic utility, limitations, and role in clinical workflows. Importantly, insights from a practicing clinical cytogeneticist highlight the increasing automation of laboratory processes and the continued relevance of karyotyping in routine diagnostics due to its cost-effectiveness and structural resolution. As genome-wide testing becomes more accessible, we explore future directions including the rise of artificial intelligence (AI), non-invasive screening technologies, and emerging ethical challenges surrounding incidental findings, data privacy, and equitable access. Together, these perspectives underscore the importance of combining technological innovation with clinical expertise and ethical foresight to guide the future of precision diagnostics.